eCommons@AKU
Community Health Sciences

Department of Community Health Sciences

11-30-2020

The relationship between birth intervals and adverse maternal and
neonatal outcomes in six low and lower-middle income countries
Melissa Bauserman
Kayla Nowak
Tracy L. Nolen
Jackie Patterson
Adrien Lokangaka

See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs
Part of the Community Health and Preventive Medicine Commons, Maternal and Child Health
Commons, Obstetrics and Gynecology Commons, and the Women's Health Commons

Authors
Melissa Bauserman, Kayla Nowak, Tracy L. Nolen, Jackie Patterson, Adrien Lokangaka, Antoinette Tshefu,
Archana B. Patel, Patricia L. Hibberd, Sarah Saleem, and Saleem Jessani

Bauserman et al. Reproductive Health 2020, 17(Suppl 2):157
https://doi.org/10.1186/s12978-020-01008-4

RESEARCH

Open Access

The relationship between birth intervals and
adverse maternal and neonatal outcomes in
six low and lower-middle income countries
Melissa Bauserman1* , Kayla Nowak2, Tracy L. Nolen2, Jackie Patterson1, Adrien Lokangaka3, Antoinette Tshefu3,
Archana B. Patel4, Patricia L. Hibberd5, Ana L. Garces6, Lester Figueroa6, Nancy F. Krebs7, Fabian Esamai8,
Edward A. Liechty9, Waldemar A. Carlo10, Elwyn Chomba11, Musaku Mwenechanya11, Shivaprasad S. Goudar12,
Umesh Ramadurg13, Richard J. Derman14, Sarah Saleem15, Saleem Jessani15, Marion Koso-Thomas16,
Elizabeth M. McClure2, Robert L. Goldenberg17 and Carl Bose1
From Global Network
Virtual. 3-15 Septemeber 2020

Abstract
Background: Due to high fertility rates in some low and lower-middle income countries, the interval between
pregnancies can be short, which may lead to adverse maternal and neonatal outcomes.
Methods: We analyzed data from women enrolled in the NICHD Global Network Maternal Newborn Health
Registry (MNHR) from 2013 through 2018. We report maternal characteristics and outcomes in relationship to the
inter-delivery interval (IDI, time from previous delivery [live or stillborn] to the delivery of the index birth), by
category of 6–17 months (short), 18–36 months (reference), 37–60 months, and 61–180 months (long). We used
non-parametric tests for maternal characteristics, and multivariable logistic regression models for outcomes,
controlling for differences in baseline characteristics.
Results: We evaluated 181,782 women from sites in the Democratic Republic of Congo, Zambia, Kenya, Guatemala,
India, and Pakistan. Women with short IDI varied by site, from 3% in the Zambia site to 20% in the Pakistan site.
Relative to a 18–36 month IDI, women with short IDI had increased risk of neonatal death (RR = 1.89 [1.74, 2.05]),
stillbirth (RR = 1.70 [1.56, 1.86]), low birth weight (RR = 1.38 [1.32, 1.44]), and very low birth weight (RR = 2.35 [2.10,
2.62]). Relative to a 18–36 month IDI, women with IDI of 37–60 months had an increased risk of maternal death (RR
1.40 [1.05, 1.88]), stillbirth (RR 1.14 [1.08, 1.22]), and very low birth weight (RR 1.10 [1.01, 1.21]). Relative to a 18–36
month IDI, women with long IDI had increased risk of maternal death (RR 1.54 [1.10, 2.16]), neonatal death (RR =
1.25 [1.14, 1.38]), stillbirth (RR = 1.50 [1.38, 1.62]), low birth weight (RR = 1.22 [1.17, 1.27]), and very low birth weight
(RR = 1.47 [1.32,1.64]). Short and long IDIs were also associated with increased risk of obstructed labor, hemorrhage,
hypertensive disorders, fetal malposition, infection, hospitalization, preterm delivery, and neonatal hospitalization.
(Continued on next page)
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Conclusions: IDI varies by site. When compared to 18–36 month IDI, women with both short IDI and long IDI had
increased risk of adverse maternal and neonatal outcomes.
Trial registration: The MNHR is registered at NCT01073475.
Keywords: Birth intervals, Developing countries, Maternal mortality, Neonatal mortality, Low birthweight, Global
network

Plain English summary
Due to high fertility rates in some low and lower-middle
income countries, the interval between pregnancies can
be short, which may lead to poor maternal and neonatal
health outcomes. We measured the time between the
delivery of one child to the delivery of the next child in
six low and lower-middle income countries. We highlight differences, by country, in the number of women
who have a short delivery interval from 4% of women in
the Zambia site to 20% of women in the Pakistan site.
We also highlight differences, by country, in the number
of women who have long delivery intervals, from 4% of
women in the Democratic Republic of Congo site to
24% of women in the Zambia site. Women with both a
short and long delivery interval have higher risk of poor
outcomes related to childbirth (obstructed labor,
hemorrhage, disorders of high blood pressure, fetal
malposition, infection and hospitalization), and poor
outcomes for their babies (neonatal death, stillbirth, preterm delivery, low birth weight and hospitalization).
Women with long delivery intervals also experience
higher risk of maternal death.
Background
High fertility rates are common in low and lower-middle
income countries (LMICs). Among the 6 LMICs included in the Eunice Kennedy Shriver National Institute
of Child Health and Human Development (NICHD)
Global Network for Women’s and Children’s Health Research (GN), fertility rates varied from 2.9 to 6.0 births
per woman [1]. High fertility rates lead to shortened
time between pregnancies, without allowing the mother
to fully recover to baseline health status prior to a subsequent gestation [2, 3]. Short intervals between pregnancies are associated with many adverse health outcomes
for the mother, including anemia, placental abruption,
placenta previa and uterine rupture [4]. Short birth intervals are also associated with adverse newborn health
outcomes such as infant mortality, preterm birth, low
birth weight (LBW) and congenital malformations [4–8].
Conversely, long birth intervals can also be associated
with adverse maternal and neonatal health outcomes,
such as increased risk for induction of labor, chorioamnionitis, Caesarean delivery, preterm birth, LBW, and
small for gestational age infants [4, 7, 9]. The ideal

timing between pregnancies associated with optimal maternal and neonatal health outcomes has not been definitively established.
The limited existing evidence on the optimal timing
between pregnancies is complicated by varying methodologies used to calculate birth spacing. Birth spacing can be defined in several ways, such as the
birth-to-pregnancy interval (the period from the prior
live birth to the conception of the index pregnancy),
the inter-pregnancy interval (the period from the
prior birth, regardless of whether the pregnancy resulted in miscarriage/stillbirth/live birth, to the conception of the index pregnancy) or the inter-delivery
interval (IDI; the period from the delivery of the prior
live birth to the delivery of the index pregnancy) [10].
In the 2005 World Health Organization (WHO)
Technical Report, an expert panel preferred birth-topregnancy interval to measure birth spacing [10].
Birth-to-pregnancy interval is challenging to measure
in low-resource settings where pregnancy dating is inaccurate and therefore length of gestation is difficult
to determine [11]. In order to calculate birth-topregnancy interval, the expert panel used delivery to
delivery interval minus 9 months, thus assuming the
index pregnancy resulted in a term gestation. This
methodology underestimates the time between births
and negates the opportunity to evaluate the effect of
birth spacing on the risk of prematurity. The use of
IDI might be more appropriate in low-resource settings to investigate associations between birth spacing
and neonatal outcomes, without introducing the bias
of unknown gestational age.
Based on limited evidence, the WHO recommends a
birth-to-pregnancy interval of 24 months, corresponding
to an IDI of approximately 33 months, for optimal maternal and neonatal outcomes [10]. After the WHO 2005
Technical Meeting on birth spacing, there was a call for
further research to better understand the effect of birth
spacing on maternal morbidity and mortality using large
datasets. In this paper, we describe IDI in a prospective,
multi-country pregnancy registry from 7 research sites
in 6 LMICs. We examine maternal characteristics associated with varying lengths of IDI as well as the relationship between adverse delivery and neonatal outcomes
and IDI.
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Methods
We analyzed data from women who were enrolled in the
NICHD GN’s Maternal Newborn Health Registry
(MNHR) from November 2013 through December 2018.
The MNHR is a multi-country, population-based,
prospectively collected record of pregnancy characteristics as well as maternal and infant outcomes [12]. The
MNHR includes research sites in North and South
Ubangi, Democratic Republic of Congo (DRC); Kafue
and Chongwe (located south and east of the capital city
of Lusaka), Zambia; Busia, Bungoma and Kakamega
(within the western region), Kenya; Chimaltenango (in
the Western Highlands), Guatemala; Belagavi and
Bagalkot (within the northern part of the southern state
of Karnataka), India; Nagpur (within the state of Maharashtra), India; and Thatta (two of the five sub-districts
in the southern Sindh province, near the city of Karachi),
Pakistan. The sites represent study clusters from both
semi-urban and rural environments.
A detailed description of the MNHR methods are described elsewhere, but briefly, MNHR data were collected from abstraction of medical records as well as a
series of interviews conducted by trained study staff [13,
14]. Maternal characteristics, including demographic information, were collected at the time a woman was
screened and consented. We also gathered information
about the prior pregnancy by maternal report at the time
of enrollment. Antenatal and delivery characteristics
were recorded within 3–7 days after delivery. Postpartum
characteristics were collected at a clinic or home visit 6
weeks after delivery. Maternal anthropometry was not
routinely collected at all sites throughout the study
period. Maternal weight was collected at the time of enrollment, however enrollment could occur at any time
during pregnancy, so these measurements do not provide a consistent reflection of nutritional status. Maternal height was collected at most sites, but this
measurement was not collected until 2017 in Kenya.
Body mass index (BMI) was calculated from maternal
height and weight, when available. Due to these methodological limitations, maternal anthropometry is presented as descriptive data only.
In this analysis, we included all women in the MNHR
with an index pregnancy during the specified time period
with the following exclusions: women who were lost to
follow up prior to delivery, primiparous women, women
without a previous pregnancy lasting greater than or equal
to 20 weeks, women with unknown parity, multiparous
women who had a missing or unknown delivery date for
the previous pregnancy, women whose index pregnancy
resulted in a miscarriage or medically terminated pregnancy (MTP), and women who had an extreme IDI (< 6
months or > 180 months (15 years)). We defined miscarriage or MTP as a pregnancy that ended prior to 20 weeks
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gestation. As we could not reliably collect data on pregnancies resulting in a miscarriage or MTP across all sites,
these pregnancies were also excluded.
We evaluated IDI in 4 categories based on distinctions
in the medical literature: 6–17 months, 18–36 months,
37–60 months, > 60 months [9]. We defined short IDI as
the interval from 6 to 17 months. We chose 6 months as
the lower limit for analysis to account for at least a 1month period for return to fecundability and an additional 5 months gestation, since we excluded index
pregnancies that resulted in miscarriage or MTP before
20 weeks / 5 months gestation. The category 18–36
months includes the WHO recommended 33 months for
optimal birth spacing and therefore was used as the referent category. We defined long IDI as > 60 months. We
calculated IDI as the number of months from the date
of delivery of the previous pregnancy (resulting in a liveborn or stillborn infant), as reported by the mother, to
the date of delivery of the index pregnancy.
To determine if the distribution of IDI differed across
sites, we performed a non-parametric Kruskal Wallis test
for overall site difference and non-parametric Wilcoxon
rank sum tests for all pairwise site comparisons. To determine the relationship between IDI and maternal characteristics, we performed Cochran-Mantel-Haenszel
tests of each maternal factor and IDI category stratified
by cluster. Risk of maternal outcomes and fetal/neonatal
outcomes associated with IDI categories were determined from multivariable generalized linear models with
general estimating equations to control for cluster level
effects. Models were adjusted for maternal age, education, parity, antenatal care (ANC) visits and iron supplementation. In the maternal risk factors model, the mode
of delivery was not included because it is not solely a
maternal risk factor and is often influenced by the occurrence of several of the other outcomes. Maternal
height, weight, and BMI were not included due to poor
data consistency. We used a Poisson distribution for the
low-prevalence outcomes of stillbirth and very low birth
weight (VLBW), all other outcomes were modeled with
a binomial distribution. We report the relative risks (RR)
and 95% confidence intervals (CIs) for each outcome by
IDI categories with the referent category of 18–36
months. Fetal/neonatal outcomes are reported at the
maternal level if at least one fetus/neonate from a multiple birth pregnancy had that outcome.
At each site, institutional review boards or research
ethics committees and Ministries of Health approved the
collection of data included in the MNHR. We used
sensitization meetings to achieve approval within local
communities prior to the initiation of the study. All
study participants were enrolled with informed consent.
A data monitoring committee appointed by the NICHD
oversaw and reviewed the MNHR annually.
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Results
We screened 314,313 pregnant women in 7 research
sites for inclusion in the MNHR from November 2013
through 2018 (Table 1). We included 312,885 (99.5%)
who were eligible and consented. After exclusion of
women with unknown parity and nulliparous women,
we retained 213,198 (68.1%) women. After exclusions for
loss to follow-up prior to delivery, MTP, unreliable prior
delivery date and IDI outlying the desired range, we included 181,782 (58.1%) women for analysis. Sites differed
in the number of nulliparous mothers (17.1% in the
Pakistan site to 49.2% in the Nagpur site). Of the 181,
782 subjects, each site contributed between 20,148 and
34,342 women for analysis (Table 2). The distribution of
IDI differed across sites overall as well as for each pairwise site comparison (p < 0.0001 for all comparisons).
The percentage of women with short IDI varied from
3.4% of women in the Zambia site to 19.8% of women in
the Pakistan site. The percentage of women with long
IDI varied from 4.1% of women in the DRC site to
23.9% of women in the Zambia site. The overall median
IDI was 32 (24, 45) months, ranging from 27 months in
the Belagavi and Pakistan sites to 43 months in the
Zambia site.
All maternal characteristics showed a statistically significant difference when evaluated by IDI (Table 3, p <
0.001 for all comparisons). Generally, as IDI lengthened,
women were more likely to be older, more educated, receive more ANC and receive more iron supplements.
Descriptive data for maternal anthropometry is included
in the supplemental material. In the multivariable
models, short and long IDI had significantly greater risk
for nearly all adverse maternal outcomes when compared to an 18–36-month IDI (Table 4). Women with a
short IDI had an increased risk of obstructed labor (RR =
1.17 [1.07, 1.28]), maternal hemorrhage (RR = 1.17 [1.04,
1.33]), hypertensive disorders (RR = 1.38 [1.19,1.61]),

fetal malposition (RR = 1.27 [1.11, 1.46]), maternal infection (RR = 1.35 [1.17, 1.56]) and maternal hospitalization
(RR = 1.31 [1.22, 1.41]). Women with a long IDI also had
increased risk of the same adverse delivery outcomes:
obstructed labor (RR = 1.54 [1.43, 1.65]), maternal
hemorrhage (RR = 1.19 [1.06, 1.32]), hypertensive disorders (RR = 2.10 [1.87, 2.36]), fetal malposition (RR = 1.34
[1.22, 1.48]), maternal infection (RR = 1.33 [1.21, 1.46]),
and maternal hospitalization (RR = 1.55 [1.43, 1.67]).
Additionally, women with a long IDI had an increased
risk of maternal mortality (RR = 1.54 [1.10, 2.16]). Overall, the adjusted RR for maternal mortality was increased
for all IDI categories relative to the 18–36-month
referent group, although only statistically significant for
37–60 months and long IDI (Fig. 1).
Similarly, short and long IDI had significantly greater
risk for nearly all adverse fetal/neonatal outcomes when
compared to an 18–36-month IDI (Table 5). Women
with a short IDI had an increased risk of LBW (RR =
1.38 [1.32, 1.44]) and VLBW (RR = 2.35 [2.10, 2.62]),
stillbirth (RR = 1.70 [1.56, 1.86]), neonatal mortality
(RR = 1.89 [1.74, 2.05]), preterm delivery (RR = 1.44
[1.39, 1.50]), and neonatal hospitalization (RR = 1.24
[1.11, 1.38]). Women with a long IDI also had increased
risk of the same adverse neonatal outcomes: LBW (RR =
1.22 [1.17, 1.27]) and VLBW (RR = 1.47 [1.32,1.64]), stillbirth (RR = 1.50 [1.38, 1.62]), neonatal mortality (RR =
1.25 [1.14, 1.38]), preterm delivery (RR = 1.06 [1.02,
1.10]), and neonatal hospitalization (RR = 1.28 [1.15,
1.43]). Overall, the adjusted RR for neonatal mortality
was increased for all IDI categories relative to the 18–
36-month referent group, although the increase at 37–
60 months was very small and not statistically significant
(Fig. 2). In contrast, the adjusted RR for stillbirth and
very low birth weight was statistically significantly increased for all IDI categories relative to the 18–36month referent group (Figs. 3 and 4).

Table 1 Derivation of Study Populationa
Screened

Total

DRC

Zambia

Kenya

Guatemala

Belagavi

Nagpur

Pakistan

314,313

32,449

36,276

40,545

57,247

51,226

47,857

48,713

Ineligible

655

0

0

0

11

0

0

644

Did not consent

773

0

0

3

757

12

0

1

Parity unknown

2686

2

8

111

2

3

30

2530

Parity = 0

97,001

6118

11,127

13,165

16,884

18,390

23,513

7804

Lost to follow-up prior to delivery

1979

415

109

398

292

3

60

702

Last delivery date missing or unknown

18,146

606

2061

1592

4370

2774

2533

4210

Miscarriage/MTP on index pregnancy

10,558

215

101

104

365

5084

1514

3175

Extreme Outlier IDIb

733

36

95

54

134

165

59

190

Deliveries Included

181,782

25,057

22,775

25,118

34,432

24,795

20,148

29,457

a

Includes deliveries and expected deliveries from November 2013 to December 2018
b
IDI’s < 6 months or > 180 months (15 years) were excluded from this analysis due to validity concerns
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Table 2 Description of IDI by Site
Total

DRC

Zambia

Kenya

Guatemala

Belagavi

Nagpur

Pakistan

181,782

25,057

22,775

25,118

34,432

24,795

20,148

29,457

6–17 months

17,392 (9.6)

1712 (6.8)

774 (3.4)

1704 (6.8)

3233 (9.4)

2589 (10.4)

1546 (7.7)

5834 (19.8)

18–36 months

91,670 (50.4)

15,937 (63.6)

7401 (32.5)

10,197 (40.6)

16,046 (46.6)

15,524 (62.6)

10,786 (53.5)

15,779 (53.6)

37–60 months

50,447 (27.8)

6389 (25.5)

9150 (40.2)

8669 (34.5)

8749 (25.4)

5044 (20.3)

5896 (29.3)

6550 (22.2)

61–180 months

22,273 (12.3)

1019 (4.1)

5450 (23.9)

4548 (18.1)

6404 (18.6)

1638 (6.6)

1920 (9.5)

1294 (4.4)

Min-Max

6–180

6–175

6–180

6–179

6–180

6–176

6–180

6–176

Median (P25-P75)

32 (24, 45)

31 (25, 38)

43 (32, 59)

38 (27, 53)

33 (23, 52)

27 (22, 38)

32 (24, 43)

27 (19, 37)

Mean (std)

37.9 (21.7)

33.3 (14.1)

48.7 (24.5)

43.4 (23.6)

41.7 (26.8)

32.4 (17.6)

36.5 (18.8)

29.7 (14.9)

Deliveries, N
IDI Categories, N (%)

a

IDI Summary Statistics

a

The Kruskal Wallis test for overall location difference across sites has a p < 0.0001. All pairwise site differences have Wilcoxon rank sum test p-values < 0.0001

Discussion
Our results indicate that IDI is associated with a number
of adverse maternal and neonatal health consequences.
We highlight differences by country in the number of
women who have a short IDI, from 3% of women in the
Zambia site to 20% of women in the Pakistan site. We

also highlight differences by country in the number of
women who have a long IDI, from 4% of women in the
Pakistan and DRC sites to 24% of women in the Zambia
site. Women with both a short and long IDI have higher
risk of adverse delivery outcomes (obstructed labor,
hemorrhage, hypertensive disorders, fetal malposition,

Table 3 Maternal Factors and Delivery Mode Associated with IDIa
IDI (months)
Deliveries, N
Maternal age, N (%)

18–36 months

37–60 months

61–180 months

17,392

91,670

50,447

22,273

17,388

91,644

50,439

22,270

< 20

1324 (7.6)

4493 (4.9)

1200 (2.4)

81 (0.4)

20–35

15,215 (87.5)

81,857 (89.3)

45,070 (89.4)

18,452 (82.9)

> 35

849 (4.9)

5294 (5.8)

4169 (8.3)

3737 (16.8)

Education, N (%)

17,388

91,649

50,444

22,268

No formal education

6607 (38.0)

26,757 (29.2)

11,530 (22.9)

3151 (14.2)

Primary

3823 (22.0)

23,147 (25.3)

11,796 (23.4)

6162 (27.7)

Secondary

6330 (36.4)

38,671 (42.2)

24,628 (48.8)

11,439 (51.4)

University+

628 (3.6)

3074 (3.4)

2490 (4.9)

1516 (6.8)

17,392

91,670

50,447

22,273

1

7520 (43.2)

36,351 (39.7)

19,353 (38.4)

7441 (33.4)

2

3437 (19.8)

20,123 (22.0)

11,350 (22.5)

5321 (23.9)

≥3

6435 (37.0)

35,196 (38.4)

19,744 (39.1)

9511 (42.7)

17,376

91,541

50,396

22,243

0

708 (4.1)

2821 (3.1)

1057 (2.1)

351 (1.6)

1–3

8167 (47.0)

39,699 (43.4)

20,258 (40.2)

8300 (37.3)

≥4

8501 (48.9)

49,021 (53.6)

29,081 (57.7)

13,592 (61.1)

17,390

91,644

50,436

22,267

15,010 (86.3)

83,671 (91.3)

47,320 (93.8)

21,423 (96.2)

17,381

91,619

50,416

22,266

Parity, N (%)

Number of ANC visits, N (%)

Iron supplements, N (%)
Yes
Mode of delivery, N (%)

a

6–17 months

Vaginal/Vaginal assisted

15,064 (86.7)

81,273 (88.7)

44,127 (87.5)

18,580 (83.4)

C-section

2317 (13.3)

10,346 (11.3)

6289 (12.5)

3686 (16.6)

All maternal factors have p-values < 0.001 for Cochran–Mantel–Haenszel tests of each maternal factor and IDI stratified by cluster
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Table 4 Risk of Adverse Delivery Outcomes Associated with IDI
IDI (months)a

Adjusted RR (95% CI)b

6–17 N (%)

18–36 N (%)

37–60 N (%)

61–180 N (%)

Deliveries

17,392

91,670

50,447

22,273

6–17 vs. 18–36

37–60 vs. 18–36

61–180 vs. 18–36

Obstructed labor

711 (4.1)

2858 (3.1)

1765 (3.5)

Maternal hemorrhage

525 (3.0)

1891 (2.1)

955 (1.9)

1007 (4.5)

1.17 (1.07, 1.28)

1.18 (1.11, 1.24)

1.54 (1.43, 1.65)

458 (2.1)

1.17 (1.04, 1.33)

1.01 (0.93, 1.10)

1.19 (1.06, 1.32)

Hypertension/pre-eclampsia/
eclampsia

359 (2.1)

1242 (1.4)

916 (1.8)

731 (3.3)

1.38 (1.19, 1.61)

1.39 (1.26, 1.54)

2.10 (1.87, 2.36)

Fetal malposition

396 (2.3)

1419 (1.5)

773 (1.5)

491 (2.2)

1.27 (1.11, 1.46)

1.03 (0.95, 1.13)

1.34 (1.22, 1.48)

Maternal infection

375 (2.3)

1217 (1.4)

625 (1.4)

323 (1.6)

1.35 (1.17, 1.56)

1.05 (0.96, 1.16)

1.33 (1.21, 1.46)

Maternal hospitalization

1109 (7.1)

4724 (5.7)

3006 (6.6)

2080 (10.1)

1.31 (1.22, 1.41)

1.17 (1.11, 1.23)

1.55 (1.43, 1.67)

Maternal death < 42 days, N
(Rate/100,000 deliveries)

35 (202)

139 (152)

94 (187)

40 (180)

1.25 (0.77, 2.02)

1.40 (1.05, 1.88)

1.54 (1.10, 2.16)

a
Columns present N (%) for each adverse delivery outcome within each IDI category with the exception of maternal death < 42 days which is presented as
rate/100,000 deliveries
b
Relative risks and 95% confidence intervals from a logistic model with generalized estimating equations to account for the correlation of outcomes within cluster
adjusting for maternal age, education, parity, ANC visits, and iron supplements. All Maternal outcomes used a Binomial distribution

infection and hospitalization) and adverse neonatal outcomes (neonatal death, stillbirth, preterm delivery, LBW,
VLBW and hospitalization). Women with a long IDI also
experience higher risk of maternal death.
Similar to other studies, we demonstrated a bimodal
distribution of adverse birth outcomes, with increased
risk among women with short and long IDI [15–17]. Of
particular note, we demonstrated an increased risk of
LBW and VLBW infants at the extremes of IDI. For
short birth intervals, this might be explained by a nutritional depletion hypothesis in which the short birth
interval results from maternal nutrient deficiency after
depletion from the previous gestational period, particularly folate deficiency, which results in impaired fetal
growth [2, 18]. However, long IDIs were also associated
with LBW infants. This finding indicates that the

nutritional depletion hypothesis is insufficient to explain
LBW among this group. Among women with a long IDI,
we observed a higher RR of hypertensive disorders. The
higher prevalence of hypertensive disorders, such as preeclampsia, might be a potential mechanism leading to
LBW infants, given the established causal relationship in
which pre-eclampsia leads to prematurity and growth restriction [19].
The findings of our study support the WHO recommendations for an optimal IDI of 33 months. When
compared to short and long intervals, the interval
around 33 months was associated with the best maternal
and neonatal outcomes. We evaluated IDI categorically
in order to compare with previous studies and evaluate
current recommendations. Analysis by categories is advantageous given the nonlinear relationship with delivery

Fig. 1 Adjusted Relative Risk for Maternal Mortality < 42 Days by IDI Categories (months)
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Table 5 Risk of Adverse Neonatal Outcomes Associated with IDIa
IDI (months)b

Adjusted RR (95% CI)c

6–17
N (%)

18–36
N (%)

37–60
N (%)

61–180
N (%)

6–17 vs. 18–36

37–60 vs. 18–36

61–180 vs. 18–36

Deliveries, N

17,392

91,670

50,447

22,273

LBW (< 2500 g)

3705 (21.4)

12,643 (13.8)

5941 (11.8)

VLBW (< 1500 g)

572 (3.3)

1128 (1.2)

567 (1.1)

2864 (12.9)

1.38 (1.32, 1.44)

1.02 (0.99, 1.05)

1.22 (1.17, 1.27)

296 (1.3)

2.35 (2.10, 2.62)

1.10 (1.01, 1.21)

1.47 (1.32, 1.64)

Preterm

3934 (22.7)

13,067 (14.3)

6403 (12.8)

2789 (12.6)

1.44 (1.39, 1.50)

0.97 (0.94, 1.00)

1.06 (1.02, 1.10)

Congenital anomalies

36 (0.2)

166 (0.2)

94 (0.2)

42 (0.2)

1.08 (0.78, 1.50)

1.13 (0.88, 1.45)

1.11 (0.78, 1.59)

Neonatal hospitalization

378 (2.5)

1518 (1.9)

742 (1.7)

470 (2.4)

1.24 (1.11, 1.38)

1.02 (0.94, 1.12)

1.28 (1.15, 1.43)

Stillbirth,
N (Rate/1000)

792 (45.6)

2219 (24.2)

1246 (24.7)

644 (28.9)

1.70 (1.56, 1.86)

1.14 (1.08, 1.22)

1.50 (1.38, 1.62)

Neonatal death
< 28 days,
N (Rate/1000)

731 (44.1)

1848 (20.7)

929 (18.9)

456 (21.1)

1.89 (1.74, 2.05)

1.04 (0.97, 1.13)

1.25 (1.14, 1.38)

a

Fetal/Neonatal outcomes are calculated at the maternal level if at least one fetus/neonate has the outcome
Columns present N (%) for each adverse delivery outcome within each IDI category, with the exception of stillbirth and neonatal death < 28 days which are
presented as rate/1000 deliveries
c
Relative risks and 95% confidence intervals from a logistic model with generalized estimating equations to account for the correlation of outcomes within cluster
adjusting for maternal age, maternal education, parity, ANC visits, and iron supplements. Very low birthweight (< 1500) and Stillbirth outcomes used a Poisson
distribution, all other Fetal/Neonatal outcomes used a Binomial distribution
b

intervals and birth outcomes [20]. While this approach
did not allow for prediction of the optimal number of
months for IDI, our robust data support the WHO recommendations of IDI of approximately 33 months.
We noted important differences in maternal characteristics by IDI. Women who had longer IDIs also had
characteristics that are usually associated with better delivery outcomes, for example older age, more education,
the receipt of more ANC, and receipt of iron supplements. Before we adjusted for these associations, it appeared that neonatal outcomes improved with increasing
IDI. However, when we adjusted for maternal

characteristics in our models, the models showed an increased risk of adverse neonatal outcomes at both lower
and higher IDI categories. This indicates that women
with long IDIs do not return to baseline risk for adverse
perinatal outcomes even with improvements in health
seeking behaviors.
Our study had a number of strengths. The MNHR
pregnancy cohort includes a large and multi-national cohort of women from Africa, Asia and Central America.
Our data were collected prospectively and included all
pregnant women within a study community, allowing
population level conclusions within those communities.

Fig. 2 Adjusted Relative Risk for Neonatal Mortality < 28 Days by IDI Categories (months)
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Fig. 3 Adjusted Relative Risk for Stillbirth by IDI Categories (months)

Our dataset allowed us to describe associated maternal
risk factors in addition to both maternal and neonatal
outcomes within this population. However, we were also
limited by some of the characteristics of the MNHR. We
were limited in our ability to assess maternal nutritional
status, therefore we are limited in our ability to address
the nutrition hypotheses that might contribute to LBW
associated with IDI. Because our studies occurred in
low-resource settings, there might have been some variability in the reliable assignment of gestational age that

could have introduced bias in our results if small for gestational age infants born at term were assigned to the
premature category. To improve interpretation of birth
weight, we chose to also evaluate LBW and VLBW separately. We chose to evaluate IDI rather than interpregnancy interval, so pregnancies that did not last more
than 20 weeks are not included. Therefore, our analyses
are limited since these pregnancies contribute to adverse
maternal and neonatal outcomes.

Fig. 4 Adjusted Relative Risk for Low Birth Weight by IDI Categories (months)
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While the social factors that determine birth spacing are
complex and include familial influences and community
level influences, there have been some intervention strategies that have been successful in lengthening birth intervals and mitigating some of the risk of adverse maternal
and neonatal health outcomes [21, 22]. For example, in
Bangladesh, a package of family planning interventions integrated into maternal and newborn health visits decreased
the number of women who had a subsequent short birth
interval and lowered the risk of preterm birth [23].

Conclusions
Our data increase the body of literature describing optimal birth intervals in relationship to maternal and newborn health outcomes in LMICs. We describe increased
health risk at extremes of birth intervals and support the
WHO recommendations for optimal birth spacing. Our
data illustrate geographical differences in IDI which
underpin the need for programmatic public health efforts to improve birth spacing in certain areas to achieve
optimal maternal and neonatal outcomes. These data
can inform communities with high rates of sub-optimal
birth spacing to direct public health strategies to the regions in most need.
Supplementary information
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